Related Experiment Video
Updated: Jul 7, 2026
09:23
Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Cdc6 knockdown inhibits human neuroblastoma cell proliferation
Luo Feng1, Jerry R Barnhart, Robert C Seeger
1Division of Hematology and Oncology, Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA 90027, USA.
Molecular and Cellular Biochemistry
|February 9, 2008
Summary
The cell division controller Cdc6 is crucial for DNA replication and cancer cell proliferation. Reducing Cdc6 levels in neuroblastoma cells suppresses tumor growth and induces cell death by affecting key cell cycle and apoptosis regulators.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The cell division controller Cdc6 is essential for initiating DNA replication.
- Elevated Cdc6 levels are observed in many human cancers and are required for tumor cell proliferation.
Purpose of the Study:
- To investigate the regulation of Cdc6 expression.
- To determine the effects of Cdc6 on cell proliferation and death in human neuroblastoma cells.
Main Methods:
- Utilized Cdc6 knockdown via short hairpin RNA lentivirus in LA-N-2 and CHLA255 neuroblastoma cell lines.
- Analyzed cell cycle progression (sub-G1, S phase content).
- Examined expression profiles of cell cycle regulators (cyclins, CDK inhibitors), apoptosis markers (Bax, Bcl-2), and p53 protein levels.
Main Results:
- Cdc6 knockdown led to sub-G1 cell cycle arrest and decreased S phase content.
- Suppression of tumor cell proliferation was indicated by reduced cyclin E, cyclin A, Cdc25C, and increased p27Kip1.
- Cdc6 knockdown induced apoptosis via increased Bax and decreased Bcl-2, and significantly reduced p53 levels post-transcriptionally.
Conclusions:
- Human Cdc6 plays a critical role in controlling cell proliferation and cell death pathways.
- Cdc6 functions in multiple pathways, including cell cycle regulation, apoptosis, and p53 stability.
- Targeting Cdc6 may represent a therapeutic strategy for neuroblastoma and other cancers.
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...